Commentary on "Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling"

Hulya Karatas
DOI: https://doi.org/10.4103/nsn.nsn_29_24
2024-10-01
Neurological Sciences and Neurophysiology
Abstract:Neuropathic pain, characterized by severe and intractable discomfort resulting from damage to the central or peripheral nervous system, poses a significant medical challenge globally. [ 1 ] Neuropathic pain development involves various pathophysiological mechanisms, including neuroinflammation and the polarization of nonneuronal cells. These processes contribute to peripheral and central sensitization by upregulating receptors or inflammatory mediators in the spinal dorsal horn and dorsal root ganglia, thereby enhancing neuronal excitability. [ 2 , 3 ] Glial cells, particularly microglia and astrocytes, play pivotal roles in this pathological process by releasing proinflammatory cytokines and chemokines. [ 2 ] Inhibitors targeting these cells have shown promise in improving hyperalgesia in animal models of neuropathic pain. Traditional pharmacological approaches, particularly opioid therapy, are associated with significant side effects and risk of abuse, highlighting the urgent need for alternative strategies. [ 4 ]
neurosciences
What problem does this paper attempt to address?